Hairy Cell Leukemia: Harnessing the Full Power of Extracellular Vesicles to Improve Patient Care Management

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Enrolling

Conditions: Hairy Cell Leukemia (HCL)

Study type: Observational

Funder types: Other

Identifiers

NCT06764524

EV-ABLE

RC-2024-2790616 (Other Grant/Funding Number)

Details and patient eligibility

About

Check whether patients with Hairy Cell Leukemia (HCL) of different status (at diagnosis, in complete remission > 2 years or relapsed requiring therapy) have a 'signature' of altered immunity based on extracellular vesicles (EV)

Full description

Extracellular vesicles are small particles detected within plasma and recognized as mediators of intercellular communication thanks to their cargo of proteins, lipids, and nucleic acids. However, the composition of vesicles from Hairy Cell Leukemia patients, which may hold the key to unraveling their involvement and function within tumor microenvironment, is totally unknown. The aim of this study is to characterize these extracellular vesicles in order to identify biology-related and disease-specific biomarkers.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria for patients:

• WHO2022-defined diagnosis of Hairy Cell Leukemia.
• age ≥18 years.
• signed informed consent.

Inclusion criteria for Healthy Donors:

• age ≥18 years.
• Volunteers in general good health, free from any disease or serious illness.
• Signed informed consent.

Exclusion criteria

• None